Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus

INTRODUCTION: Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely prescribed for type 2 diabetes (T2D) and their glycemic control effects are well studied. However, information regarding the effects of switching DPP-4 inhibitors is limited, especially in older patients. RESEARCH DESIGN AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Eugene, Lee, Minyoung, Lee, Yong-ho, Kim, Hye Soon, Lee, Byung-wan, Cha, Bong-Soo, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646502/
https://www.ncbi.nlm.nih.gov/pubmed/33173319
http://dx.doi.org/10.2147/DMSO.S267994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646502/
https://www.ncbi.nlm.nih.gov/pubmed/33173319
http://dx.doi.org/10.2147/DMSO.S267994

Ejemplares similares